Search clinical trials for: Nivolumab Relatimab SC

Total 237151 results

Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company

Completed

A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.

Genital Neoplasms, Female | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Pelvic Neoplasms

United States
Memorial Sloan Kettering Cancer Center

Completed

A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery

Prostate Cancer

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Inappropriate ADH Syndrome | Water Intoxication | Hyponatremias | Water-Electrolyte Imbalances

United States
Northeastern Ohio Universities College of Medicine
Pfizer; U.S. Army Medical Research and Development Command; Louis Stokes VA Medical... and other collaborators

Unknown

Restless Legs Syndrome Exercise Intervention

Restless Legs Syndrome | Insomnia
Eli Lilly and Company
Boehringer Ingelheim

Completed

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Medical University of Vienna

Completed

Endothelin-Receptor Blockade in Coronary Heart Disease

Vascular Resistance | Coronary Vessels | Endothelins

Austria
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

United States, Lithuania, Puerto Rico, Romania, Russian Federation
University of Mississippi Medical Center
Kyowa Hakko Kogyo Co., Ltd.

Completed

Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis

Seasonal Allergic Rhinitis

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company

Completed

Efficacy Study of LY2422347 to Treat Insomnia

Sleep Initiation and Maintenance Disorders

United States
Eli Lilly and Company

Completed

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Attention-Deficit/Hyperactivity Disorder | Comorbid Dyslexia

United States
Eli Lilly and Company

Completed

Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients

Osteoporosis

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States
Eli Lilly and Company

Completed

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

Superficial Bladder Cancer

Italy
Shaare Zedek Medical Center

Unknown

PAR Family Polymorphisms and Placental Invasion Disorders

Miscarriage, Recurrent | Premature Labor
Eli Lilly and Company

Completed

Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes

Attention-Deficit/Hyperactivity Disorder

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Stress Urinary Incontinence

United States
Boston Scientific Corporation

Completed

Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure

Congestive Heart Failure

United States
University of Texas Southwestern Medical Center
Biogen

Completed

Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis

Multiple Sclerosis

United States
Geha Mental Health Center

Unknown

Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study

Depression

Israel
University of Pittsburgh

Completed

Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation

Abortion, Induced

United States
Boston Scientific Corporation

Completed

Safety and Effectiveness of Cardiac Resynchronization Therapy With Defibrillation

Ventricular Fibrillation | Tachycardia, Ventricular | Heart Failure, Congestive

United States
Sheba Medical Center

Suspended

Simulation Training as a Tool to Decrease Occupational Stress in ICU Personnel

Education, Health

Israel
Sheba Medical Center

Unknown

Anti-Aggregative Therapy and Laser Iridectomy

Eyes With Narrow Angle

Israel
National Center for Complementary and Integrative...

Completed

Shamanic Healing for Women With Temporomandibular Joint Disorders (TMDs)

Temporomandibular Disorders

United States
Sheba Medical Center

Unknown

T-Cell Vaccination in Multiple Sclerosis (MS)

Multiple Sclerosis

Israel
Sheba Medical Center

Withdrawn

Simulation Training as a Tool for Teamwork Improvement in Multidisciplinary Intensive Care Team

Education, Health

Israel
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women

Menopause, Premature | Hysterectomy | Attitude | Perception | Ovariectomy | Estrogen Replacement Therapy

Taiwan
Sunnybrook Health Sciences Centre
Ontario Lung Association

Unknown

Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP)

Premature Birth | Respiratory Insufficiency

Canada
Sheba Medical Center

Unknown

Early Movements as a Predictor of Future Developmental Delay

Cerebral Palsy | Premature Birth

Israel
Shanghai Jiao Tong University School of Medicine
National Institutes of Health (NIH)

Completed

Therapeutic Effects of Berberine in Patients With Type 2 Diabetes

Type 2 Diabetes

China
BZL Biologics

Completed

Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2

Prostatic Neoplasms

United States
Charite University, Berlin, Germany

Terminated

Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

Germany
Assaf-Harofeh Medical Center

Unknown

the Role of Total Body Imaging in Asymptomatic Pediatric Trauma Patients

Injuries and Wounds
Instituto Nacional de Cardiologia Ignacio Chavez

Unknown

Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy

Acute Kidney Failure

Mexico
Indiana University School of Medicine

Terminated

Galantamine Augmentation of Escitalopram for Treatment of Depression

Depression

United States
Pfizer

Terminated

Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease

Parkinson Disease

Colombia, United States, Argentina, Puerto Rico
French National Agency for Research on AIDS and...

Terminated

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

HIV Infections

France
Assaf-Harofeh Medical Center
Ferring Pharmaceuticals

Unknown

The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator

Osteoarthritis of the Knee

Israel
Gilead Sciences

Completed

A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering Drugs

Hypertension
Sheba Medical Center

Unknown

The Usefulness of HyperQ Recordings for the Early Diagnosis of Acute Coronary Syndrome in Patients Presenting With Chest Pain

Acute Coronary Syndrome

Israel

Search clinical trials for: Nivolumab Relatimab SC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations